143 related articles for article (PubMed ID: 34868309)
1. Metabolomics Identifies Biomarker Signatures to Differentiate Pancreatic Cancer from Type 2 Diabetes Mellitus in Early Diagnosis.
Xu H; Zhang L; Kang H; Liu J; Zhang J; Zhao J; Liu S
Int J Endocrinol; 2021; 2021():9990768. PubMed ID: 34868309
[TBL] [Abstract][Full Text] [Related]
2. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
[TBL] [Abstract][Full Text] [Related]
3. The serum metabolic profiles of different Barcelona stages hepatocellular carcinoma associated with hepatitis B virus.
Zhang L; Wu GY; Wu YJ; Liu SY
Oncol Lett; 2018 Jan; 15(1):956-962. PubMed ID: 29399157
[TBL] [Abstract][Full Text] [Related]
4. LC/MS-based discrimination between plasma and urine metabolomic changes following exposure to ultraviolet radiation by using data modelling.
Ali AM; Monaghan C; Muggeridge DJ; Easton C; Watson DG
Metabolomics; 2023 Feb; 19(2):13. PubMed ID: 36781606
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of urine metabolic profile in patients with hepatocellular carcinoma].
Chen X; Zhang L; Wu YJ; Liu SY; Liu HP
Zhonghua Gan Zang Bing Za Zhi; 2021 Aug; 29(8):788-793. PubMed ID: 34517462
[No Abstract] [Full Text] [Related]
6. [Urinary metabolomics study of renal cell carcinoma based on gas chromatography-mass spectrometry].
Zhang L; Li L; Kong H; Zeng F
Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):763-6. PubMed ID: 26018279
[TBL] [Abstract][Full Text] [Related]
7. Development of a metabolite calculator for diagnosis of pancreatic cancer.
Choi M; Park M; Lee SH; Lee MJ; Paik YK; Jang SI; Lee DK; Lee SG; Kang CM
Cancer Med; 2023 Aug; 12(15):15933-15944. PubMed ID: 37350558
[TBL] [Abstract][Full Text] [Related]
8. Identification of psoriasis vulgaris biomarkers in human plasma by non-targeted metabolomics based on UPLC-Q-TOF/MS.
Li SS; Liu Y; Li H; Wang LP; Xue LF; Yin GS; Wu XS
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3940-3950. PubMed ID: 31115022
[TBL] [Abstract][Full Text] [Related]
9. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
Xiong Y; Shi C; Zhong F; Liu X; Yang P
Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
[TBL] [Abstract][Full Text] [Related]
10. High-Performance Liquid Chromatography-Mass Spectrometry-Based Lipid Metabolite Profiling of Acromegaly.
Wang M; Guo S; He M; Shao X; Feng L; Yu Y; Gong W; Liu Q; Melnikov V; Wang X; He Z; Jiang L; Chen M; Sun J; Cai J; Zhao Y; Li Y; Tritos NA; Hu Z; Zhang Z
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31930294
[TBL] [Abstract][Full Text] [Related]
11. Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma.
Liu SY; Zhang RL; Kang H; Fan ZJ; Du Z
World J Gastroenterol; 2013 Jun; 19(22):3423-32. PubMed ID: 23801834
[TBL] [Abstract][Full Text] [Related]
12. LC-MS-Based Untargeted Metabolomics Reveals Early Biomarkers in STZ-Induced Diabetic Rats With Cognitive Impairment.
Chen R; Zeng Y; Xiao W; Zhang L; Shu Y
Front Endocrinol (Lausanne); 2021; 12():665309. PubMed ID: 34276557
[TBL] [Abstract][Full Text] [Related]
13. Chemical Fingerprint Analysis and Ultra-Performance Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry-Based Metabolomics Study of the Protective Effect of Buxue Yimu Granule in Medical-Induced Incomplete Abortion Rats.
Zhang Y; Li W; Chen TT; Yang Y; Wu MY; Luo JY; Gong Y; Zou L
Front Pharmacol; 2020; 11():578217. PubMed ID: 33328985
[TBL] [Abstract][Full Text] [Related]
14. [Metabolomics study of Danggui Buxue Tang on treatment of type 2 diabetes mice using UHPLC-Q-TOF-MS].
Sun LL; Bai HY; Zheng WH; Wang LY; Zhao W; Li JY; Shi YB; Yang ZG
Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):636-644. PubMed ID: 32237524
[TBL] [Abstract][Full Text] [Related]
15. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
[TBL] [Abstract][Full Text] [Related]
16. Specific sweat metabolite profile in ocular Behcet's disease.
Cui X; Zhang L; Su G; Kijlstra A; Yang P
Int Immunopharmacol; 2021 Aug; 97():107812. PubMed ID: 34091113
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
18. A serum metabolomic analysis for diagnosis and biomarker discovery of primary biliary cirrhosis and autoimmune hepatitis.
Lian JS; Liu W; Hao SR; Chen DY; Wang YY; Yang JL; Jia HY; Huang JR
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):413-21. PubMed ID: 26256087
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients.
Qiu Y; Zhou B; Su M; Baxter S; Zheng X; Zhao X; Yen Y; Jia W
Int J Mol Sci; 2013 Apr; 14(4):8047-61. PubMed ID: 23584023
[TBL] [Abstract][Full Text] [Related]
20. Plasma metabolic biomarkers for discriminating individuals with alcohol use disorders from social drinkers and alcohol-naive subjects.
Mostafa H; Amin AM; Teh CH; Murugaiyah VA; Arif NH; Ibrahim B
J Subst Abuse Treat; 2017 Jun; 77():1-5. PubMed ID: 28476260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
